Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

novartis_window

Novartis CEO sets aside $700 million to settle bribery lawsuit

July 18, 2019 Business Services, Sales and Marketing Novartis, bribery, lawsuit, pharma, sales

Vas Narasimhan, Novartis’ CEO, has set aside $700 million to settle a bribery lawsuit in the United States. Speaking in …
News
pixnio-drone

Autonomous drone successfully delivers temperature-controlled drugs in test programme

July 17, 2019 Research and Development, Sales and Marketing Drones, humanitarian aid, pharma

A humanitarian consortium has successfully completed a testing programme for the delivery of temperature-controlled medicines via the use of unmanned …
News
Bayer image

Bayer’s Gadavist becomes first FDA-approved drug for MRI in coronary artery disease patients

July 16, 2019 Manufacturing and Production, Sales and Marketing Bayer, FDA, Gadavist, coronary artery disease, pharma

The FDA has awarded approval to Bayer’s Gadavist (gadobutrol) injection, the company confirmed.
News
darius_hughes

Darius Hughes, Head of Vaccines Business Unit UK, Pfizer

July 15, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Darius Hughes, Pfizer, Working Life, biotech, pharma, vaccines

“Vaccines provide a unique opportunity to have a positive effect on hundreds of thousands of people” – Darius Hughes, Head …
Feature
ema_logo

FDA and EMA fully implement mutual recognition agreement between US and EU

July 15, 2019 Sales and Marketing EMA, FDA, GMP, Slovakia, mra, mutual recognition, pharma

The FDA has recognised Slovakia’s ability to carry out inspections of manufacturing facilties. The recognition of Slovakia marks the full …
News
astrazeneca_building_white

AstraZeneca’s Farxiga fails to get FDA approval for patients with Type 1 diabetes

July 15, 2019 Sales and Marketing AstraZeneca, EMA, FDA, US, diabetes, farxiga

The FDA had said it will not approve AstraZeneca’s diabetes drug Farxiga for use as a supplement to insulin in …
News
gsk_boronia_australia

GSK’s Zejula meets primary endpoint in Phase 3 trial of patients with ovarian cancer

July 15, 2019 Sales and Marketing

British multinational GlaxoSmithKline has said ovarian cancer drug Zejula (niraparib) met its primary endpoint in a Phase 3 trial. Zejula …
News
gilead-sciences

Gilead invests $5.1 billion into Galapagos NV

July 15, 2019 Sales and Marketing Galapagos, Gilead, biotech, collaboration, deal, drug discovery, pharma

Gilead has entered into a 10 year partnership with Belgo-Dutch biotech Galapagos NV. The collaboration will see Gilead invest $5.1 …
News

Generex Biotechnology acquires Medisource Partners

July 15, 2019 Sales and Marketing Generex, Medisource, medical supplies, medicines, pharma, surgery

Canadian firm Generex Biotechnology has acquired Texas-based medical and surgical products distributor Medisource Partners. Under the terms of the deal …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

July 12, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HPV, NHS, NICE, Novartis, Pfizer, Trump, pharma, vaccines

This week’s most popular story covered news of Trump’s claims that he will introduce an executive order to ensure the …
News

Scottish NHS patients to access Pfizer’s Ibrance combo in HR+/HER- breast cancer following SMC recommendation

July 11, 2019 Sales and Marketing Cancer, Scotland, Scottish Medicines Consortium, breast cancer, ibrance, pharma

Female NHS patients in Scotland will soon be able to access Pfizer’s cyclin-dependent kinase (CDK) 4/6 inhibitor Ibrance (palbociclib) after …
News
dr_kim_branson

GSK hires computational drug design expert Dr Kim Branson as new head of machine learning and AI

July 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

British multinational GlaxoSmithKline have hired computational drug design expert Dr Kim Branson as the company’s new Senior Vice President, Global …
Appointment
epipen

Novartis aims to solve EpiPen shortage with generic launch of Symjepi to US pharmacies

July 10, 2019 Manufacturing and Production, Research and Development, Sales and Marketing Mylan, Novartis, Sandoz, US, epipen, pharma

Novartis has announced the immediate availability of its generic epinephrine auto-injector in pharmacies throughout the US, as it moves to …
News

NICE recommends Alnylam’s Onpattro for inherited hATTR amyloidosis

July 9, 2019 Manufacturing and Production, Sales and Marketing Alnylam, NHS, Onpattro, UK, hATTR amyloidosis, pharma

It’s good news for UK patients as it emerges that the National Institute of Health and Care Excellence has passed …
News
blockchain-3750157_640

Insider Interview: A roadblock for counterfeit drugs?

July 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA, blockchain, fake drugs, feature, pharma

Dr Thomas Endress, Founder, and Dr Frederic Berkermann, co-?Founder, of a new technology being developed at the Merck Innovation Center …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025